Qinmei Xiong

Qinmei Xiong

Auto-generated profile, based on publicly available information

Qinmei Xiong

Department of Cardiology The Second Affiliated Hospital, Nanchang University Nanchang China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2016 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Open access
PDF file
YLYee Cheng Lau
Yee Cheng Lau
QXQinmei Xiong
Qinmei Xiong
ESEduard Shantsila
Eduard Shantsila
Gregory LipGregory Lip
Gregory Lip
ABAndrew Blann
Andrew Blann
Non-vitamin K antagonist oral anticoagulants (NOACs) are replacing warfarin and heparins in several clinical situations. With varying modes of action, the effects of NOACs on thrombus formation, integrity, and lysis is unknown. To determine whether two techniques of thrombelastography (TEG) and a micro-plate assay (MPA) provide novel data on thrombus formation, integrity and lysis in those taking a NOACs compared to warfarin and a control group taking aspirin. We assessed thrombogenesis, clot integrity and fibrinolysis in blood (TEG) and plasma (MPA) from 182 atrial fibrillation patients—50 on aspirin, 50 on warfarin, and 82 on a NOAC (17 apixaban, 19 dabigatran and 46 rivaroxaban). Eleven of 16 TEG indices and 4 of 5 MPA indices differed (p ≤ 0.01) between those on aspirin, warfarin or a NOAC. Three TEG indices and 4 MPA indices differed (p < 0.01) between the NOACs. Time to initiation of clot formation was most rapid on apixaban, then rivaroxaban and slowest on dabigatran. The rate of clot formation was most rapid on dabigatran, then apixaban, and slowest on rivaroxaban. Clot density was greatest on rivaroxaban, then apixaban, but weakest on dabigatran. The rate of clot dissolution was most rapid in apixaban, then dabigatran, and slowest on rivaroxaban. The TEG and MPA identify major differences in thrombogenesis and fibrinolysis in different NOACs. These techniques may have value in investigating the effects of these drugs on haemostasis in a clinical setting, and in identifying those in need of targeted therapy.

29 January 2024 in Clinical Cardiology
Verified
Journal Article
Open access
JHJuan Hua
Juan Hua
QXQinmei Xiong
Qinmei Xiong
QKQiling Kong
Qiling Kong
LXLiang Xiong
Liang Xiong
QHQianghui Huang
Qianghui Huang
QCQi CHen
Qi CHen
Background: Pulsed field ablation (PFA) has emerged as a novel non‐thermal modality with highly myocardium‐specific. However, the PFA catheter based on contact force (CF)‐sensing has not been reported. The study aimed to evaluate the efficacy and safety of a novel CF‐sensing PFA catheter.Methods: First, different CF (5, 15, 25, and 35 g) of the novel PFA catheter were evaluated on lesion dimensions during ablation on right and left ventricle in two pigs. Next, this catheter was further evaluated on four typical sites of superior vena cava (SVC), cavotricuspid isthmus (CTI), right superior pulmonary vein (RSPV), and right inferior pulmonary vein (RIPV) for atrial ablation in another six pigs. Electrical isolation was evaluated immediately after ablation and 30‐day survival. Chronic lesions were assessed via histopathology after euthanasia. Acute and chronic safety outcomes were observed peri‐ and post‐procedurally.Results: In ventricular ablation, increased CF from 5 to 15 g produced significantly greater lesion depth but nonsignificant increases from 15 to 35 g. In atrial ablation, the novel CF‐sensing PFA deliveries produced an acute attenuation of local electrograms and formation of a continuous line of block in all 6 pigs. The ablation line remained sustained blockage at the 30‐day survival period. The CF of SVC, CTI, RSPV, and RIPV was 9.4 ± 1.5, 14.5 ± 3.2, 17.2 ± 2.6, and 13.4 ± 2.8 g, respectively. Moreover, no evidence of damage to esophagus or phrenic nerve was observed.Conclusion: The novel CF‐sensing PFA catheter potentiated efficient, safe, and durable ablation, without causing damage to the esophagus or phrenic nerve.

30 March 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
YWYan Wang
Yan Wang
HLHeng Li Lai
Heng Li Lai
QCQi CHen
Qi CHen
HLHao Liu
Hao Liu
QLQiming liu
Qiming liu
DWDaowen Wang
Daowen Wang
Aims: A few studies have reported the effect and safety of pulsed field ablation (PFA) catheters for ablating atrial fibrillation (AF), which were mainly based on basket-shaped or flower-shaped designs. However, the clinical application of a circular-shaped multi-electrode catheter with magnetic sensors is very limited. To study the efficacy and safety of a PFA system in patients with paroxysmal AF using a circular-shaped multi-electrode catheter equipped with magnetic sensors for pulmonary vein isolation (PVI). Methods and results: A novel proprietary bipolar PFA system was used for PVI, which utilized a circular-shaped multi-electrode catheter with magnetic sensors and allowed for three-dimensional model reconstruction, mapping, and ablation in one map. To evaluate the efficacy, efficiency, and safety of this PFA system, a prospective, multi-centre, single-armed, pre-market clinical study was performed. From July 2021 to December 2022, 151 patients with paroxysmal AF were included and underwent PVI. The study examined procedure time, immediate success rate, procedural success rate at 12 months, and relevant complications. In all 151 patients, all the pulmonary veins were acutely isolated using the studied system. Pulsed field ablation delivery was 78.4 ± 41.8 times and 31.3 ± 16.7 ms per patient. Skin-to-skin procedure time was 74.2 ± 29.8 min, and fluoroscopy time was 13.1 ± 7.6 min. The initial 11 (7.2%) cases underwent procedures with deep sedation anaesthesia, and the following cases underwent local anaesthesia. In the initial 11 cases, 4 cases (36.4%) presented transient vagal responses, and the rest were all successfully preventatively treated with atropine injection and rapid fluid infusion. No severe complications were found during or after the procedure. During follow-up, 3 cases experienced atrial flutter, and 11 cases had AF recurrence. The estimated 12-month Kaplan–Meier of freedom from arrhythmia was 88.4%. Conclusion: The PFA system, comprised of a circular PFA catheter with magnetic sensors, could rapidly achieve PVI under three-dimensional guidance and demonstrated excellent safety with comparable effects.

1 August 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
XLXiao Luo
Xiao Luo
QXQinmei Xiong
Qinmei Xiong
JXJingsong Xu
Jingsong Xu
KHKui Hong
Kui Hong
QPQiang Peng
Qiang Peng
SHSu Hai
Su Hai

6 November 2021 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
QXQinmei Xiong
Qinmei Xiong
JHJinzhu Hu
Jinzhu Hu
QZQiongqiong Zhou
Qiongqiong Zhou
LHLin Huang
Lin Huang
JYJianhua Yu
Jianhua Yu
KHKui Hong
Kui Hong
With the steadily increasing amount of leadless pacemaker implantations performed worldwide, it has called attention to the delivery difficulty in patients with severe large right heart. Nevertheless, limited studies have reported leadless pacemaker implantation in patients with tricuspid stenosis. Here, we report the successful implantation of leadless pacemaker in a 60‐year‐old female patient with giant right atrium and tricuspid valve stenosis. It is highlighted that leadless pacemaker should not be discouraged even if there are tricuspid valve stenosis and giant right atrium.

16 October 2023
Verified
Preprint
Open access
PDF file
QXQinmei Xiong
Qinmei Xiong
JHJinzhu Hu
Jinzhu Hu
QDQuanbin Dong
Quanbin Dong
LXLiang Xiong
Liang Xiong
QHQianghui Huang
Qianghui Huang
KHKui Hong
Kui Hong
Introduction: Atrial tachycardia(AT) occurring from the right atrial appendage(RAA) is relatively uncommon, while the catheter ablation is complicated by the anatomic characteristics. Methods: We reported a case of 60-year-old male patient who was admitted with incessant AT. Results: The tachycardia activation mapping demonstrated that the AT originated from the tip of RAA. Pulsed field ablation(PFA) using the circular mapping&PFA catheter terminated AT without any complication. Conclusions: This case corroborates that PFA might be an alternative strategy for ablation of atrial arrhythmia originating from the atrial appendage.